Published April 29, 2026 | Version v1
Presentation Open

What's new in 2025 for Sjögren's disease?

Authors/Creators

  • 1. EDMO icon University of Sydney
  • 2. ROR icon Westmead Hospital
  • 3. ROR icon Westmead Institute for Medical Research

Files

2026.04.29 - SjD 2025 Update.pdf

Files (1.7 MB)

Name Size Download all
md5:76672142134cc0bcc31cb9314d121681
1.7 MB Preview Download

Additional details

References

  • Baldini et al. Update on the pathophysiology and treatment of primary Sjögren syndrome. Nat Rev Rheumatol. 2024;20(8):473-491. doi: 10.1038/s41584-024-01135-3
  • Deboo et al. Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease. Arthritis Care Res (Hoboken). 2025. doi: 10.1002/acr.70004
  • Lee AYS et al. Phases and Natural History of Sjögren's Disease: A New Model for an Old Disease? Arthritis Care Res (Hoboken). 2023;75(7):1580-1587. doi: 10.1002/acr.25011
  • Nguyen Y et al. Lancet Rheumatol. 2024;6(4):e216-e225. doi: 10.1016/S2665-9913(23)00340-5
  • Pelkas C et al. Novel therapies in Sjögren's disease: A systematic review of the literature. Best Pract Res Clin Rheumatol. 2025;39(4):102084. doi: 10.1016/j.berh.2025.102084
  • Ramos-Casals M et al. 2023 International Rome consensus for the nomenclature of Sjögren disease. Nat Rev Rheumatol. 2025;21(7):426-437. doi: 10.1038/s41584-025-01268-z
  • Tang Y et al. The role of epithelial cells in the immunopathogenesis of Sjögren's syndrome. J Leukoc Biol. 2024;115(1):57-67. doi: 10.1093/jleuko/qiad049